ABVX
Income statement / Annual
Last year (2025), Abivax's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Abivax's net income was -$336.10 M.
See Abivax,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$63.00 K |
$2.00 K |
$18.00 K |
$10.00 K |
$127.00 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$50.76 M
|
$45.52 M
|
$33.78 M
|
$28.19 M
|
$15.38 M
|
$14.51 M
|
$14.65 M
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
-$50.76 M
|
-$45.52 M
|
-$33.78 M
|
-$28.19 M
|
-$15.36 M
|
-$14.50 M
|
-$14.52 M
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
-536.24
|
-14093
|
-853.28
|
-1449.7
|
-114.31
|
| Research and Development Expenses |
$177.76 M
|
$146.53 M
|
$103.18 M
|
$48.30 M
|
$47.78 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$72.64 M
|
$37.97 M
|
$28.11 M
|
$7.49 M
|
$5.58 M
|
$5.60 M
|
$4.89 M
|
$4.30 M
|
$3.78 M
|
$3.56 M
|
| Selling & Marketing Expenses |
$224.00 K
|
$932.00 K
|
$709.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$72.87 M
|
$38.90 M
|
$28.82 M
|
$7.49 M
|
$5.58 M
|
$5.60 M
|
$4.89 M
|
$4.30 M
|
$3.78 M
|
$3.56 M
|
| Other Expenses |
-$4.57 M
|
-$12.45 M
|
-$4.62 M
|
-$41.72 M
|
-$57.48 M
|
-$1.37 M
|
$218.00 K
|
-$549.00 K
|
-$4.13 M
|
$160.00 K
|
| Operating Expenses |
$246.06 M
|
$172.98 M
|
$127.38 M
|
$14.07 M
|
-$4.12 M
|
$4.23 M
|
$5.11 M
|
$3.75 M
|
-$347.00 K
|
$3.72 M
|
| Cost And Expenses |
$246.06 M
|
$172.98 M
|
$127.38 M
|
$64.84 M
|
$41.40 M
|
$38.01 M
|
$33.30 M
|
$19.13 M
|
$14.16 M
|
$18.36 M
|
| Interest Income |
$5.75 M
|
$8.96 M
|
$2.77 M
|
$0.00
|
$0.00
|
$0.00
|
$14.00 K
|
$79.00 K
|
$116.00 K
|
$301.00 K
|
| Interest Expense |
$28.48 M
|
$12.43 M
|
$13.83 M
|
$6.94 M
|
$3.56 M
|
$2.06 M
|
$1.59 M
|
$469.00 K
|
$0.00
|
$42.00 K
|
| Depreciation & Amortization |
$1.07 M
|
$1.10 M
|
$707.00 K
|
$485.00 K
|
$302.00 K
|
$66.00 K
|
$80.00 K
|
$71.00 K
|
$93.00 K
|
-$35.00 K
|
| EBITDA |
-$300.70 M |
-$162.71 M |
-$133.21 M |
-$53.32 M |
-$38.59 M |
-$38.00 M |
-$33.22 M |
-$19.23 M |
-$13.98 M |
-$17.86 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
-603.16
|
-16611
|
-1068.17
|
-1398
|
-140.64
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
-603.3
|
-16648
|
-1061.56
|
-1415
|
-143.59
|
| Total Other Income/Expenses Net |
-$84.20 M
|
-$3.26 M
|
-$20.36 M
|
$4.10 M
|
-$1.05 M
|
-$40.13 M
|
-$1.59 M
|
-$687.00 K
|
$77.00 K
|
$258.00 K
|
| Income Before Tax |
-$330.25 M
|
-$176.24 M
|
-$147.74 M
|
-$60.74 M
|
-$42.45 M
|
-$40.13 M
|
-$34.89 M
|
-$19.80 M
|
-$14.07 M
|
-$17.98 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
-636.94
|
-17444
|
-1099.72
|
-1407.3
|
-141.56
|
| Income Tax Expense |
$5.85 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$2.58 M
|
-$4.26 M
|
-$3.97 M
|
-$2.69 M
|
-$3.52 M
|
| Net Income |
-$336.10 M
|
-$176.24 M
|
-$147.74 M
|
-$60.74 M
|
-$42.45 M
|
-$37.55 M
|
-$30.63 M
|
-$15.82 M
|
-$11.22 M
|
-$14.31 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
-596.05
|
-15317
|
-879.06
|
-1122.3
|
-112.66
|
| EPS |
-4.65 |
-2.8 |
-3.43 |
-3.18 |
-2.75 |
-2.62 |
-2.51 |
-1.56 |
-1.14 |
-1.48 |
| EPS Diluted |
-4.65 |
-2.8 |
-3.43 |
-3.18 |
-2.75 |
-2.62 |
-2.51 |
-1.55 |
-1.13 |
-1.47 |
| Weighted Average Shares Out |
$69.53 M
|
$63.05 M
|
$43.07 M
|
$19.09 M
|
$15.46 M
|
$14.31 M
|
$12.18 M
|
$10.18 M
|
$9.87 M
|
$9.65 M
|
| Weighted Average Shares Out Diluted |
$69.53 M
|
$63.05 M
|
$43.07 M
|
$19.09 M
|
$15.46 M
|
$14.31 M
|
$12.18 M
|
$10.21 M
|
$9.93 M
|
$9.73 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
